Global and China Artificial Intelligence Drug R&D Market Size, Status and Forecast 2021-2027

Global and China Artificial Intelligence Drug R&D Market Size, Status and Forecast 2021-2027

  • QYResearch
  • January 2022
  • Software
  • 107 pages

Report Description

Global Artificial Intelligence Drug R&D Scope and Market Size
Artificial Intelligence Drug R&D market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Artificial Intelligence Drug R&D market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
AI Platfrom
Analytics Service

Segment by Application
Drug Discovery
Precision Medicine

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
IBM Watson
BioXel
Insilico Medicine
Gatehouse Bio
Google DeepMind
Genpact Cora
Cyclica Inc
QuantumBlack
Nq Medical
Phenomic AI
Palantir Technologies

Have query on this report?

Make an Enquiry
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence Drug R&D Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 AI Platfrom
List of Tables
Table 1. Global Artificial Intelligence Drug R&D Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of AI Platfrom
Table 3. Key Players of Analytics Service
Table 4. Global Artificial Intelligence Drug R&D Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Artificial Intelligence Drug R&D Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027

Success Stories

Our Clients